Literature DB >> 8662705

Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4.

H Herwald1, T Renné, J C Meijers, D W Chung, J D Page, R W Colman, W Müller-Esterl.   

Abstract

Prekallikrein, the precursor to the serine proteinase kallikrein, circulates in plasma in an equimolar complex with H-kininogen. The binding to H-kininogen is mediated by the kallikrein heavy chain consisting of four "apple" domains, A1-A4, which attaches to H-kininogen with high specificity and affinity (KD = 83 nM). At least two distinct portions of the kallikrein heavy chain form this H-kininogen binding site: a proximal segment located in the NH2-terminal fragment of the heavy chain encompassing A1, and distal segment(s) located in COOH-terminal fragment spanning domains A2-A4. The proximal binding segment has been located to amino acid positions 56-86 of A1. To precisely map the distal binding segment, we have identified monoclonal antibodies directed to the COOH-terminal fragment which interfere with the H-kininogen-prekallikrein complex formation. Monoclonal antibody 13G11 binds to recombinant apple domain A4 but not to domain A3 of the prekallikrein heavy chain. Deletion mutagenesis of domain A4 narrowed down the target epitope of 13G11 to the center portion of domain A4, positions 284-331. Direct binding studies of H-kininogen to various domain A4 constructs revealed that the distal H-kininogen binding portion is located on a segment of 48 residues, which overlaps the 13G11 epitope. Hence the tight interaction of H-kininogen and prekallikrein is mediated by at least two separate sequence segments located in domains A1 and A4, respectively, of the prekallikrein heavy chain. The isolated distal binding segment significantly prolongs the partial thromboplastin time of reconstituted Williams plasma thus stressing the critical role of the prekallikrein-H-kininogen complex formation in the initiation of the endogenous blood coagulation cascade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662705     DOI: 10.1074/jbc.271.22.13061

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  In vivo roles of factor XII.

Authors:  Thomas Renné; Alvin H Schmaier; Katrin F Nickel; Margareta Blombäck; Coen Maas
Journal:  Blood       Date:  2012-09-19       Impact factor: 22.113

2.  Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).

Authors:  R A Pixley; R G Espinola; B Ghebrehiwet; K Joseph; A Kao; K Bdeir; D B Cines; R W Colman
Journal:  Thromb Haemost       Date:  2011-05-05       Impact factor: 5.249

3.  Core cysteine residues in the Plasminogen-Apple-Nematode (PAN) domain are critical for HGF/c-MET signaling.

Authors:  Debjani Pal; Kuntal De; Carly M Shanks; Kai Feng; Timothy B Yates; Jennifer Morrell-Falvey; Russell B Davidson; Jerry M Parks; Wellington Muchero
Journal:  Commun Biol       Date:  2022-07-01

4.  The unique architecture and function of cellulose-interacting proteins in oomycetes revealed by genomic and structural analyses.

Authors:  Mathieu Larroque; Roland Barriot; Arnaud Bottin; Annick Barre; Pierre Rougé; Bernard Dumas; Elodie Gaulin
Journal:  BMC Genomics       Date:  2012-11-09       Impact factor: 3.969

5.  Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.

Authors:  Vassiliki Lila Koumandou; Andreas Scorilas
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.